In a roundup of highlights from day three of its annual meeting, DIA includes two panels moderated by Catalyst. As part of the coverage, DIA has posted videos of select portions of each one, including:

  • Precision Medicine – Rob Califf, FDA Deputy Commissioner for Medical Products, discusses the promise of Precision Medicine, and current challenges
  • 21st Century Cures initiative – Janet Woodcock, CDER Director, talks about why she considers the patient-focused drug development provisions to be the “most transformative” part of the Cures bill, and highlights a few of the components of this “long-term project”